AB-729
AB-729-201
Phase 2 small_molecule completed
Quick answer
AB-729 for Chronic Hepatitis b is a Phase 2 program (small_molecule) at Arbutus Biopharma Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arbutus Biopharma Corp
- Indication
- Chronic Hepatitis b
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed